Xin Lang Cai Jing·2026-02-04 07:56Core Viewpoint - Spring Medical experienced a decline of 1.24% on February 4, with a trading volume of 49.12 million yuan and a total market capitalization of 8.834 billion yuan [1] Company Overview - Spring Medical is a leading domestic orthopedic medical device manufacturer, focusing on the research, production, and sales of implantable orthopedic medical devices, including oral metal and invisible orthodontics, as well as oral implants and restorations [2][5] - The company is currently in the design and inspection phase for a customized porous tantalum dental implant product [2] - Spring Medical has obtained registration certificates for hip and knee surgical robots and medical image processing software, indicating its investment in smart medical technology [2][3] Industry Position - The company has been recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, which is a prestigious title in the national evaluation of small and medium-sized enterprises, highlighting its strong innovation capabilities and market share [3] - Spring Medical's main products include joint prosthetics and spinal implants, covering major human joints such as hip, knee, shoulder, and elbow, as well as a full range of spinal internal fixation systems [5][8] Financial Performance - For the period from January to September 2025, Spring Medical achieved a revenue of 756 million yuan, representing a year-on-year growth of 48.75%, and a net profit attributable to shareholders of 192 million yuan, with a year-on-year increase of 213.21% [8] - The company has distributed a total of 440 million yuan in dividends since its A-share listing, with 390 million yuan in the last three years [8] Shareholder Information - As of September 30, 2025, the top ten circulating shareholders include Hong Kong Central Clearing Limited and Central European Economic Selection Mixed A, both of which are new shareholders [9]